Family considerations drove several of Patrick Rivelli’s career choices but did not prevent him from having brilliant triumphs. Success as a consultant was followed by success as an executive. This led him to found his first company and to fund another startup. The most eloquent evidence of his achievements was exiting two biotech startups in …
What if an injection could cure your diabetes? Meng Deng, PhD and Karen Wurster were on the podcast to talk about Adipo Therapeutics’ ambitious plan to remake the metabolism of diabetic people. Informative and accessible. HIGHLIGHTS INCLUDE Sal Daher Introduces the Founder and the CEO of Adipo Therapeutics “…we’re talking about having too much white …
Meng Deng and Karen Wurster, “Convert Fat to Cure Diabetes” Read More »
A successful founder who has become a respected angel investor in Boston, Raza Shaikh is a pleasure to speak to and to learn from. Raza also has a podcast called On Boards which is great for people who are on boards or would like to be. HIGHLIGHTS Sal Daher Introduces Raza Shaikh, Founder, Angel & …
4,000 people per year die in the US from uncontrolled epilepsy, many of them young. Vivek Ganesh and Jay Shah started Neurava to build sensors and algorithms to prevent such deaths. Here’s my chat with these doctoral candidates from Purdue trying to bring their tech from the lab to the market. HIGHLIGHTS Sal Daher Introduces …
“Controlling Epilepsy” with Vivek Ganesh and Jay Shah Read More »
A terrible error in a lab led Tim Spong to start a company to improve the reliability and efficiency of pathology labs; big industry players are noticing. This interview was part of my due diligence on Tim’s startup, VistaPath Bio. Subsequently, I invested in the company. Highlights Sal Daher Introduces Tim Spong, Co-Founder of VistaPath …
Repeat biotech founder Todd Zion on SmartCells (acquired by Merck for $500MM) and his current venture Akston Bio which is doing cool things with proteins. Todd has valuable insights on VC funding, angel investing, and founding teams. This interview’s a peach! Highlights: Intro of Todd Zion, PhD Co-Founder of SmartCells (Merck) and Akston Bio Todd …
Todd Zion, PhD, CEO and Repeat Founder, “Magical Proteins” Read More »
By Sal Daher, CFA The miracle of the mRNA COVID vaccines, brought to us by two startups, leaves no doubt as to the promise of biotech. While experts expected the vaccines to take years, these startups designed theirs in days and were saving millions in a matter of months. The icing on the cake is …
By Sal Daher, CFA Early-stage biotech investing has been the preserve of deep-pocketed investors where angels have feared to tread. The reasons include that it takes a long time to train life scientists, that biology is hard, that life sciences need specialized laboratories with expensive equipment, and that biotechnologies have long and costly product cycles. …
How Angel Investing in Biotech Differs from Investing in Software Read More »
